Arginine

arginine vasopressin ; Homo sapiens







30 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35528828 Copeptin Levels Before and After Transsphenoidal Surgery for Cushing Disease: A Potential Early Marker of Remission. 2022 Jun 1 1
2 34175655 Role of copeptin in the diagnosis of traumatic neuroendocrine dysfunction. 2021 Oct 1
3 34181038 Acute Effects of Vasopressin Arginine Infusion in Children with Congenital Heart Disease: Higher Blood Pressure Does Not Equal Improved Systemic Oxygen Delivery. 2021 Dec 1
4 34181566 Oxytocin levels in response to pituitary provocation tests in healthy volunteers. 2021 Aug 3 2
5 34597810 Dysregulation of the renin-angiotensin system in septic shock: Mechanistic insights and application of angiotensin II in clinical management. 2021 Dec 1
6 34659087 Endolymphatic Sac Drainage Surgery and Plasma Stress Hormone Vasopressin Levels in Meniere's Disease. 2021 1
7 32236441 Effect of Arginine on the Hypothalamic-Pituitary-Adrenal Axis in Individuals With and Without Vasopressin Deficiency. 2020 Jul 1 4
8 32387127 Diagnosis and differential diagnosis of diabetes insipidus: Update. 2020 Sep 1
9 33317692 [Copeptin is a new diagnostic biomarker for diabetes insipidus]. 2020 Dec 14 1
10 33380527 Hypotonic polyuria: at the cross-roads of copeptin. 2020 Dec 1
11 31656992 Vasopressin and Copeptin in health and disease. 2019 Sep 1
12 30011137 The diagnostic and prognostic value of copeptin in cardiovascular disease, current status, and prospective. 2018 Nov 2
13 17904379 Abundant b-type ions produced in electron capture dissociation of peptides without basic amino acid residues. 2007 Nov 1
14 11845867 Interaction between vasodilators and vasopressin in internal mammary artery and clinical significance. 2002 Feb 2
15 12121494 Comparison between the influence of the intravenous and intracerebroventricular injection of a nitric oxide donor on adrenocorticotropic hormone release and hypothalamic neuronal activity. 2002 Jul 1
16 12356298 Apparent loss-of-function mutant GPCRs revealed as constitutively desensitized receptors. 2002 Oct 8 1
17 10071789 Discovery and design of novel vasopressin hypotensive peptide agonists. 1999 Jan-Jul 2
18 10583317 Enhancement of the GH responsiveness to GH releasing stimuli by lysine vasopressin in type 1 diabetic subjects. 1999 Oct 1
19 8868303 Probing the V1a vasopressin receptor binding site with pyroglutamate-substituted linear antagonists. 1996 Feb 1
20 7534728 Role of nitric oxide in the regulation of renin and vasopressin secretion. 1994 Dec 1
21 7689960 Nitric oxide modulates the release of vasopressin from rat hypothalamic explants. 1993 Sep 1
22 8376600 Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels. 1993 Sep 1
23 8383455 Endothelial L-arginine pathway and relaxations to vasopressin in canine basilar artery. 1993 Feb 5
24 1935933 Conformation of [8-arginine]vasopressin and V1 antagonists in dimethyl sulfoxide solution derived from two-dimensional NMR spectroscopy and molecular dynamics simulation. 1991 Oct 15 1
25 1999249 Cyclic and linear vasopressin V1 and V1/V2 antagonists containing arginine in the 4-position. 1991 Jan 15 1
26 3260096 High-dose vasopressin for acute variceal hemorrhage. Clinical advantages without adverse effects. 1988 Jul 1
27 3383999 Effects of vasopressin on the human non-pregnant uterus: studies with analogues of different vasopressor potencies. 1988 Mar 22 1
28 2960813 Potent vasopressin antagonists modified at the carboxy-terminal tripeptide tail. 1987 Dec 1
29 3021739 Purification and characterization of a paired basic residue-specific prohormone-converting enzyme from bovine pituitary neural lobe secretory vesicles. 1986 Nov 5 4
30 2300 Partial purification and characterization of post-proline cleaving enzyme: enzymatic inactivation of neurohypophyseal hormones by kidney preparations of various species. 1976 Jan 23 2